Wang Lai
Insider CIK 1852291 · BGNE President, Global Head of R&D
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ONC BeOne Medicines Ltd. | S Sale | 2026-06-23 | 2026-06-25 | 1,068 | $276.74 | $295.6K | 0 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2026-06-16 | 2026-06-18 | 1,169 | $265.39 | $310.2K | 0 | SEC↗ |
| ONC BeOne Medicines Ltd. | A Award deriv | 2026-06-11 | 2026-06-15 | 229,775 | — | $0 | 229,775 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2026-06-11 | 2026-06-15 | 756 | $261.00 | $197.3K | 0 | SEC↗ |
| ONC BeOne Medicines Ltd. | A Award | 2026-06-11 | 2026-06-15 | 118,625 | — | $0 | 1,710,085 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2026-06-08 | 2026-06-10 | 1,327 | $269.34 | $357.4K | 40 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2026-06-08 | 2026-06-10 | 40 | $270.73 | $10.8K | 0 | SEC↗ |
| ONC BeOne Medicines Ltd. | A Award | 2026-03-06 | 2026-03-10 | 55,029 | — | $0 | 1,619,059 | SEC↗ |
| ONC BeOne Medicines Ltd. | A Award | 2026-03-06 | 2026-03-10 | 112,606 | — | $0 | 1,564,030 | SEC↗ |
| ONC BeOne Medicines Ltd. | A Award | 2025-12-31 | 2026-01-05 | 427,895 | — | $0 | 1,451,424 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2025-09-09 | 2025-09-11 | 5,000 | $350.06 | $1.75M | 0 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2025-07-30 | 2025-07-31 | 259 | $305.00 | $79.0K | 0 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2025-07-29 | 2025-07-31 | 800 | $304.16 | $243.3K | 259 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2025-07-29 | 2025-07-31 | 2,949 | $302.00 | $890.6K | 1,351 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2025-07-29 | 2025-07-31 | 292 | $302.92 | $88.5K | 1,059 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2025-07-18 | 2025-07-22 | 700 | $300.00 | $210.0K | 0 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2025-06-23 | 2025-06-25 | 1,028 | $260.00 | $267.3K | 0 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2025-06-17 | 2025-06-18 | 470 | $251.37 | $118.1K | 0 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2025-06-16 | 2025-06-18 | 1,177 | $266.40 | $313.6K | 470 | SEC↗ |
| ONC BeOne Medicines Ltd. | A Award deriv | 2025-06-10 | 2025-06-12 | 162,565 | — | $0 | 162,565 | SEC↗ |
| ONC BeOne Medicines Ltd. | A Award | 2025-06-10 | 2025-06-12 | 86,359 | — | $0 | 1,058,304 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2025-06-06 | 2025-06-10 | 202 | $251.89 | $50.9K | 600 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2025-06-06 | 2025-06-10 | 300 | $255.30 | $76.6K | 0 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2025-06-06 | 2025-06-10 | 600 | $250.71 | $150.4K | 802 | SEC↗ |
| ONC BeOne Medicines Ltd. | S Sale | 2025-06-06 | 2025-06-10 | 300 | $253.19 | $76.0K | 300 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2025-03-05 | 2025-03-07 | 69,251 | — | $0 | 990,171 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2025-02-21 | 2025-02-25 | 479 | $256.70 | $123.0K | 2,619 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2025-02-21 | 2025-02-25 | 1,327 | $254.82 | $338.1K | 3,673 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2025-02-21 | 2025-02-25 | 575 | $255.86 | $147.1K | 3,098 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2025-02-21 | 2025-02-25 | 437 | $258.18 | $112.8K | 2,182 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2025-02-21 | 2025-02-25 | 1,782 | $258.73 | $461.1K | 400 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2025-02-21 | 2025-02-25 | 400 | $260.17 | $104.1K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2024-09-27 | 2024-10-01 | 5,000 | $220.35 | $1.10M | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2024-06-24 | 2024-06-26 | 2 | $161.10 | $322 | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2024-06-24 | 2024-06-26 | 1,062 | $159.80 | $169.7K | 2 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2024-06-18 | 2024-06-20 | 841 | $153.75 | $129.3K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2024-06-17 | 2024-06-20 | 478 | $159.00 | $76.0K | 1,626 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2024-06-17 | 2024-06-20 | 485 | $159.42 | $77.3K | 1,141 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2024-06-17 | 2024-06-20 | 300 | $159.90 | $48.0K | 841 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2024-06-17 | 2024-06-20 | 237 | $158.50 | $37.6K | 2,104 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2024-06-05 | 2024-06-07 | 318,253 | — | $0 | 318,253 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2024-06-05 | 2024-06-07 | 168,935 | — | $0 | 1,768,962 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2023-06-26 | 2023-06-27 | 1,103 | $181.91 | $200.6K | 5 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2023-06-26 | 2023-06-27 | 5 | $183.15 | $916 | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2023-06-20 | 2023-06-20 | 1,325 | $192.42 | $255.0K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2023-06-15 | 2023-06-20 | 507,234 | — | $0 | 507,234 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2023-06-15 | 2023-06-20 | 133,627 | — | $0 | 1,614,431 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2023-06-07 | 2023-06-09 | 161 | $224.04 | $36.1K | 227 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2023-06-07 | 2023-06-09 | 116 | $226.15 | $26.2K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2023-06-07 | 2023-06-09 | 74 | $223.23 | $16.5K | 388 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2023-06-07 | 2023-06-09 | 111 | $225.27 | $25.0K | 116 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2022-06-27 | 2022-06-28 | 458 | $177.32 | $81.2K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2022-06-22 | 2022-06-24 | 707,876 | — | $0 | 707,876 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2022-06-22 | 2022-06-24 | 125,255 | — | $0 | 1,509,989 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2022-06-21 | 2022-06-22 | 723 | $149.01 | $107.7K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2022-06-17 | 2022-06-22 | 445 | $139.40 | $62.0K | 723 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2022-06-06 | 2022-06-08 | 660 | $142.00 | $93.7K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2022-05-17 | 2022-05-19 | 233,948 | — | $0 | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2022-05-17 | 2022-05-19 | 999,999 | — | $0 | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2022-05-17 | 2022-05-19 | 999,999 | $3.49 | $3.49M | 1,408,498 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2022-05-17 | 2022-05-19 | 233,948 | $2.29 | $535.7K | 408,499 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2021-12-15 | 2021-12-17 | 0 | $30.13 | $0 | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | G Gift | 2021-10-31 | 2021-12-17 | 58,188 | — | $0 | 58,188 | SEC↗ |
| BGNE BeiGene, Ltd. | G Gift | 2021-10-31 | 2021-12-17 | 58,188 | — | $0 | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | G Gift | 2021-09-28 | 2021-12-17 | 58,188 | — | $0 | 174,551 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-06-28 | 2021-06-30 | 455 | $362.48 | $164.9K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-06-18 | 2021-06-21 | 802 | $331.15 | $265.6K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2021-06-16 | 2021-06-21 | 332,527 | — | $0 | 332,527 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2021-06-16 | 2021-06-21 | 53,625 | — | $0 | 238,654 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-06-07 | 2021-06-09 | 656 | $354.26 | $232.4K | 0 | SEC↗ |